| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Oj Medtech Inc is a Bay Shore, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Quality Progressions is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fort Hudson Nursing Home Inc is a Fort Edward, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
At Hyperice, our mission is to provide everyone with the most innovative technology in accelerating recovery time, preventing injury, and enhancing the body`s ability to move more efficiently. All Hyperice products are developed and tested to meet the standards of the world`s best athletes.